Figure 3From: Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosusChange in anti-dsDNA antibodies. Mean percentage change from baseline in 31 patients whose anti-dsDNA antibody levels were 10 IU/ml or greater. dsDNA, double-stranded DNA.Back to article page